Thrilled and proud to start my journey as an Internal Medicine resident at Sinai Baltimore. This achievement is the result of years of hard work, dedication, and perseverance. Grateful for everyone who supported me along the way-excited for what’s ahead 💕 #Match2025@AAPPHealth
@Apichatka@KirkWangensteen Had an amazing visit to @psuconnext connecting with the brilliant and welcoming GIH and translational science faculty and trainees. Excited for a thriving partnership between PSU and Mayo Clinic as we join forces in the fight against HCC! 🧬👩🔬🧑🔬🌏
Excited to share that my abstract has been accepted for presentation at the NCCN Conference! Grateful for the opportunity to contribute to advancing cancer care and connect with experts in the field. Looking forward to meaningful discussions ! #NCCN2025#HCC@MayoClinicGIHep
Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort
#OpenAccess here👉https://t.co/RHR4b5sjg6
#LiverTwitter
✨ Met Prof Manal Hassan @MDAndersonNews.
✨ @Perapa_C from @MayoClinic
✨ Dr. Matt Cooley @AfricaHPBCC and excellent individuals.
Grateful to have had this exposure to not just learn but also to connect with great minds involved work in HPB cancer management across Africa
13
Grateful to have attended the 2024 @AfricaHPBCC conference
I caught up with collaborators, connected with rising trainees, and expanded my perspective on hepatopancreatobiliary cancer research in Africa 🌍
@Kekeli_Fortune@kristitofunmi @DrNasraGiama @GivenNdhlov@EdwinAdoga
@JoseDebesMD speaking @AfricaHPBCC in Mombasa: “African hepatitis B network”
✅Rural vs urban care
✅Creativity in care: liver cancer surveillance provided once diagnosed with Hep B! Creativity is performing the ultrasound in the back seat of the car! get it done
#GlobalHealth
Currently @ NBO airport, ready to head to the 2024 @AfricaHPBCC conference ✈️ 🇰🇪🌍
Excited to forge connections, present our projects with @KirkWangensteen, and immerse in Kenyan culture.
Special thanks to the Mayo Clinic Global Health Program for the scholarship 🙏🏻
Exciting! single dose siRNA against PNPLA3 ⬇️⬇️ steatosis in >90% Hispanic cohort
@NEJM@MarcoArreseMD@AASLDtweets@alehlatam
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD https://t.co/z7uBjL7Hkj